Your search returned 118 studies. (Get alerts for new studies):
- Donor Lymphocyte Infusion in Treating Patients With Persistent, Relapsed, or Progressing Cancer After Donor Hematopoietic Cell Transplant
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid Leukemia With Del(5q) - Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) - Adult Acute Myeloid Leukemia With t(15;17)(q22;
2 Locations available
- Vorinostat, Cytarabine, and Etoposide in Treating Patients With Relapsed and/or Refractory Acute Leukemia or Myelodysplastic Syndromes or Myeloprolife
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
2 Locations available
- Study of VELCADE® With Mitoxantrone and Etoposide for Leukemias
Conditions: Relapsed Acute Leukemia - Refractory Acute Leukemia
1 Location available
- Dose Escalation Phase I/II Study of Lovastatin With High-Dose Cytarabine for Refractory or Relapsed AML
Conditions: Acute Myeloid Leukemia
1 Location available
- Reduced Intensity Conditioning With Clofarabine, Antithymocyte Globulin (ATG), Total Lymphoid Irradiation (TLI) Followed by Allogeneic Stem Cell Trans
Conditions: Acute Myeloid Leukemia - Myelodysplastic Syndrome - Acute Lymphocytic Leukemia - Relapsed/Refractory Chronic Lymphocytic Leukemia - Relapsed/Refractory Non Hodgkin's Lymphoma - Hodgkins Disease - Relapsed Refractory Multiple Myeloma
2 Locations available
- A Trial of the Combination 5-azacitidine and Gemtuzumab Ozogamicin Therapy for Treatment of Relapsed Acute Myeloid Leukemia (AML)
Conditions: Acute Myeloid Leukemia
2 Locations available
- A Study of Decitabine in Combination With Escalating Doses of Rapamycin in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Conditions: Acute Myeloid Leukemia
1 Location available
- A Study of the Safety and Preliminary Efficacy of Oral Midostaurin (PKC412) in Relapsed or Refractory Pediatric Leukemia
Conditions: Acute Myeloid Leukemia - Acute Lymphoblastic Leukemia
4 Locations available
- DT2219ARL Immunotoxin in Treating Patients With B-Cell Leukemia or Lymphoma That Has Relapsed or Not Responded to Treatment
Conditions: Leukemia - Lymphoma
3 Locations available
- A Phase I Clinical Trial of OXi4503 for Relapsed and Refractory AML and MDS
Conditions: Leukemia, Myelogenous, Acute - Myelodysplastic Syndromes
1 Location available
- Alvespimycin Hydrochloride in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-Cell Prolymphocytic Leuke
Conditions: Leukemia - Lymphoma
1 Location available
- Bortezomib, Mitoxantrone, Etoposide, and Cytarabine in Relapsed or Refractory Acute Myeloid Leukemia
Conditions: Adult Acute Megakaryoblastic Leukemia (M7) - Adult Acute Minimally Differentiated Myeloid Leukemia (M0) - Adult Acute Monoblastic Leukemia (M5a) - Adult Acute Monocytic Leukemia (M5b) - Adult Acute Myeloblastic Leukemia With Maturation (M2) - Adult Acute
1 Location available
- INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Unspecified Childhood Solid Tumor, Protocol Specific
24 Locations available
- Dasatinib With Fludarabine and Rituximab in Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Conditions: Chronic Lymphocytic Leukemia - Small Lymphocytic Lymphoma
2 Locations available
- Bortezomib and Midostaurin With or Without Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Conditions: Acute Myeloid Leukemia - Acute Myeloid Leukemia With Multilineage Dysplasia Following - Myelodysplastic Syndrome - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid Leukemia With Del(5q) - Adult Acute Myeloid Leukemia With
1 Location available
- Pentostatin, Cyclophosphamide, and Rituximab Followed By Alemtuzumab in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leuke
Conditions: Leukemia
140 Locations available
- Fenretinide in Treating Patients With Refractory or Relapsed Hematologic Cancer
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm
4 Locations available
- Therapy for Pediatric Relapsed or Refractory Acute Lymphoblastic Leukemia
Conditions: Acute Lymphoblastic Leukemia - Lymphoma, Lymphoblastic
2 Locations available
- ABT-888 and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggres
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Myelodysplastic Syndromes
1 Location available
- A Study of ARRY-520 in Patients With Relapsed or Refractory Multiple Myeloma
Conditions: Multiple Myeloma - Plasma Cell Leukemia
5 Locations available
- Mismatched Donor Lymphocyte Infusions for Relapsed Disease Following Allogeneic Stem Cell Transplantation
Conditions: Leukemia, Myeloid, Acute - Leukemia, Lymphoblastic, Acute - Leukemia, Myelocytic, Chronic
1 Location available
- A Phase I Study of GNKG186 in Patient With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL)
Conditions: Leukemia
4 Locations available
- A Phase 1-2 Study of CAT-8015 in Adult Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
Conditions: Chronic Lymphocytic Leukemia (CLL) - Diffuse Large B-Cell Lymphoma (DLBCL) - Non-Hodgkin's Lymphoma (NHL) - Follicular Lymphoma (FL) - Mantle Cell Lymphoma (MCL)
1 Location available
- Bortezomib and Azacitidine in Treating Patients With Relapsed or Refractory T-Cell Lymphoma
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - Hepatosplenic T-cell Lymphoma - Peripheral T-cell Lymphoma - Post-transplant Lymphoproliferative Disorder - Prolymphocytic Leukemia - Re
1 Location available
- AR-42 in Treating Patients With Advanced or Relapsed Multiple Myeloma, Chronic Lymphocytic Leukemia, or Lymphoma
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - Cutaneous B-cell Non-Hodgkin Lymphoma - Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue - Hepatosplenic T-
1 Location available
- Trial of Sirolimus and Methotrexate in Relapsed/Refractory Lymphoblastic Leukemia and Lymphoma
Conditions: Cancer - Leukemia - Lymphoma
1 Location available
- Penostatin, Rituximab and Ontak and Allogeneic Natural Killer (NK) Cells for Refractory Lymphoid Malignancies
Conditions: Relapsed Lymphoma - B Cell Non-Hodgkin Lymphoma - Refractory Lymphoma - High Risk Chronic Lymphocytic Leukemia
1 Location available
- A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia and Non-Hod
Conditions: Chronic Lymphocytic Leukemia - Non-Hodgkin's Lymphoma
4 Locations available
- Carfilzomib in Treating Patients With Relapsed or Refractory T-Cell Lymphoma
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - Peripheral T-cell Lymphoma - Recurrent Adult T-cell Leukemia/Lymphoma
1 Location available
- Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobul
Conditions: B Cell Non-Hodgkin's Lymphoma - Chronic Lymphocytic Leukemia - Waldenstrom Macroglobulinemia
13 Locations available
- Entinostat And Imatinib Mesylate In Treating Patients With Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Conditions: Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia - Recurrent Adult Acute Lymphoblastic Leukemia
1 Location available
- Ruxolitinib Phosphate (Oral JAK Inhibitor INCB18424) in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell or Peripheral T-Cell Non-Ho
Conditions: Peripheral T-cell Lymphoma - Recurrent Adult Diffuse Large Cell Lymphoma - Recurrent Adult T-cell Leukemia/Lymphoma
1 Location available
- Intensity-Modulated Radiation Therapy, Etoposide, and Cyclophosphamide Followed By Donor Stem Cell Transplant in Treating Patients With Relapsed or Re
Conditions: Leukemia
1 Location available
- Pentostatin, Alemtuzumab, and Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Conditions: Leukemia - Lymphoma
3 Locations available
- Clofarabine and Cytarabine in Treating Older Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes That Have Relapsed or Not Res
Conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid Leukemia With Del(5q) - Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) - Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) - Adult Acute Myeloid Leukemia With t(8;21)(
1 Location available
- Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Conditions: Leukemia - Lymphoma
97 Locations available
- Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias
Conditions: Leukemia-relapsed or Refractory - Cancer
13 Locations available
- Azacitidine in Treating Patients With Relapsed Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia Who Have Undergone
Conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid Leukemia With Del(5q) - Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) - Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) - Adult Acute Myeloid Leukemia With t(16;16)
1 Location available
- A Study of Escalating Doses of DCDS4501A in Patients With Relapsed or Refractory B-Cell Non Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia
Conditions: Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia
5 Locations available
- Cladribine, Cytarabine, and Imatinib Mesylate in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Blastic Phase Chronic Myeloge
Conditions: Leukemia
1 Location available
- Combination Chemotherapy and Alemtuzumab in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
Conditions: Leukemia
64 Locations available
- Dose Escalation Trial of WT1-Sensitized T Cells for Residual or Relapsed Leukemia After Allogeneic Hematopoietic Progenitor Cell Transplantation
Conditions: Leukemia - Myelodysplastic Syndrome
1 Location available
- Infusion of Genetically Modified T Cell for Post Transplant Patients With Relapsed Disease
Conditions: Leukemia - Lymphoma, Non-Hodgkin - Hodgkin Disease - Myelodysplastic Syndromes - Multiple Myeloma
1 Location available
- Sorafenib in Combination With Cytarabine and Clofarabine in Patients With Refractory or Relapsed Hematologic Malignancies
Conditions: Acute Myeloid Leukemia - Infantile Leukemia (Both AML and ALL) - Myelodysplastic Syndrome - Myelodysplastic/Myeloproliferative Neoplasms - Biphenotypic Leukemia
1 Location available
- RAD001 Study in Treatment of Relapsed or Refractory Acute Lymphocytic Leukemia
Conditions: Leukemia - Acute Lymphocytic Leukemia
1 Location available
- Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
Conditions: Relapsed T-Cell Acute Lymphoblastic Leukemia - Relapsed T-Cell Lymphoblastic Lymphoma
20 Locations available
- A Phase I Trial Using Cyclophosphamide, Rituximab and Revlimid (CR2) for the Treatment of Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia (B-C
Conditions: Leukemia, Lymphocytic, Chronic, B-Cell - Chronic Lymphocytic Leukemia - Lymphoma, Small Lymphocytic
1 Location available
- Entinostat and Sorafenib Tosylate in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory or Relapsed Acute Myeloid Leukemia
Conditions: Leukemia - Unspecified Adult Solid Tumor, Protocol Specific
2 Locations available
- Rituximab for Patients With Relapsed Acute Lymphoblastic Leukemia
Conditions: Leukemia - Acute Lymphoblastic Leukemia - ALL
3 Locations available
- AKT Kinase Inhibitor MK-2206 With Relapsed Refractory Acute Myelogenous Leukemia
Conditions: Leukemia
1 Location available
- Sapacitabine, Cyclophosphamide, Rituximab for Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma (CLL/SLL) With Deletion (11q22-23)
Conditions: Leukemia
1 Location available
- Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)
Conditions: Acute Lymphoblastic Leukemia
2 Locations available
- Ofatumumab and Dinaciclib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-Cell Prolymp
Conditions: Leukemia - Lymphoma
1 Location available
- A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Conditions: Chronic Lymphocytic Leukemia (CLL)
4 Locations available
- Eltrombopag Olamine in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia
Conditions: Adult Acute Eosinophilic Leukemia - Adult Acute Megakaryoblastic Leukemia (M7) - Adult Acute Minimally Differentiated Myeloid Leukemia (M0) - Adult Acute Monoblastic Leukemia (M5a) - Adult Acute Monocytic Leukemia (M5b) - Adult Acute Myeloblastic Leukemia
1 Location available
- Sorafenib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia
Conditions: Leukemia - Unspecified Childhood Solid Tumor, Protocol Specific
21 Locations available
- Donor Stem Cell Transplant in Treating Young Patients With Acute Myeloid Leukemia With Monosomy 7, -5/5q-, High FLT3-ITD AR, or Refractory or Relapsed
Conditions: Leukemia
48 Locations available
- Everolimus and Bortezomib in Treating Patients With Relapsed or Refractory Lymphoma
Conditions: 714leukemia - Lymphoma
1 Location available
- Vorinostat, Cladribine, and Rituximab in Treating Patients With Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia, or Relapsed B-Cell Non-Hodgkin Lym
Conditions: Leukemia - Lymphoma
1 Location available
- Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL
Conditions: Chronic Lymphocytic Leukemia - Small Lymphocytic Lymphoma
10 Locations available
- Study to Investigate CAL-101 in Combination With Chemotherapeutic Agents and CD20 mAb in Patients With Relapsed or Refractory Indolent B-cell Non-Hodg
Conditions: Indolent Non-Hodgkin's Lymphoma - Chronic Lymphocytic Leukemia - Mantle Cell Lymphoma
11 Locations available
- CMC-544 in Relapsed Refractory Acute Lymphoblastic Leukemia (ALL)
Conditions: Acute Lymphoblastic Leukemia
1 Location available
- Bendamustine Hydrochloride, Rituximab, Etoposide, and Carboplatin in Treating Patients With Relapsed or Refractory Lymphoid Malignancies and Select Un
Conditions: Adult Grade III Lymphomatoid Granulomatosis - Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - Chronic Lymphocytic Leukemia - Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma - Con
1 Location available
- Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia
Conditions: Chronic Lymphocytic Leukemia (CLL)
7 Locations available
- A Study of the Safety and Pharmacokinetics of Escalating Doses of DCDT2980S in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and
Conditions: Chronic Lymphocytic Leukemia - Non-Hodgkin's Lymphoma
6 Locations available
- Lenalidomide and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Recurrent Adult Acute Myeloid Leukemia
1 Location available
- A Study of ARRY-520 and Bortezomib Plus Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma
Conditions: Multiple Myeloma, Plasma Cell Leukemia
3 Locations available
- Bortezomib, Vorinostat and Dexamethasone for Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL)
Conditions: Acute Lymphoblastic Leukemia
1 Location available
- Single Agent Lenalidomide in Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
Conditions: Leukemia - Adult Acute Lymphocytic Leukemia
1 Location available
- Decitabine and Vaccine Therapy for Patients With Relapsed AML Following Allogeneic Stem Cell Transplantation
Conditions: Acute Myelogenous Leukemia
1 Location available
- A Pilot Study of Decitabine and Vorinostat With Chemotherapy for Relapsed ALL
Conditions: Acute Lymphoblastic Leukemia - Precursor B-Cell Lymphoblastic Leukemia - Precursor T-Cell Lymphoblastic Leukemia
2 Locations available
- Bortezomib, Rituximab, Cyclophosphamide, and Prednisone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma
Conditions: Leukemia - Lymphoma
4 Locations available
- Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
Conditions: Leukemia
70 Locations available
- Azacytidine and Bortezomib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes
Conditions: Leukemia - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
1 Location available
- JVRS-100 for the Treatment of Patients With Relapsed or Refractory Leukemia
Conditions: Leukemia
1 Location available
- A Pilot Study of the Safety and Activity of Escalating Doses of ON 01910.Na in Patients With Relapsed Mantle Cell Lymphoma, Multiple Myeloma, Chronic
Conditions: Lymphoma, Mantle-Cell - Leukemia, Lymphocytic, Chronic, B-Cell - Leukemia, Hairy Cell - Waldenstrom Macroglobulinemia - Multiple Myeloma
1 Location available
- Vorinostat, Gemtuzumab Ozogamicin, and Azacitidine in Treating Older Patients With Relapsed or Refractory Acute Myeloid Leukemia
Conditions: Leukemia
3 Locations available
- Obatoclax Mesylate, Vincristine Sulfate, Doxorubicin Hydrochloride, and Dexrazoxane Hydrochloride in Treating Young Patients With Relapsed or Refracto
Conditions: Leukemia - Lymphoma - Unspecified Childhood Solid Tumor, Protocol Specific
18 Locations available
- Safety Study: Combination of Decitabine and Midostaurin in Patients Older Than 60 With Newly Diagnosed or Relapsed Refractory Acute Myeloid Leukemia
Conditions: Acute Myeloid Leukemia
1 Location available
- Cladribine Based Induction Therapy With All-Trans Retinoic Acid and Midostaurin in Relapsed/Refractory AML
Conditions: Leukemia, Myeloid, Acute
1 Location available
- Multi-center Trial of Revlimid® and Rituximab for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Conditions: Chronic Lymphocytic Leukemia - CLL
1 Location available
- A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma
Conditions: Adult T Cell Leukemia - Adult T Cell Lymphoma
12 Locations available
- Phase 1 Study of Combotox With Cytarabine in Relapsed/Refractory B-lineage Acute Lymphoblastic Leukemia (ALL)
Conditions: B-cell Adult Acute Lymphoblastic Leukemia - Acute Lymphoblastic Leukemia
1 Location available
- Phase II Ofatumumab/Methylprednisolone Followed by Ofatumumab/Lenalidomide for Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic L
Conditions: Chronic Lymphocytic Leukemia (CLL) - Small Lymphocytic Lymphoma (SLL)
1 Location available
- Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
Conditions: Leukemia
153 Locations available
- Combination Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Leukemia
Conditions: Leukemia
1 Location available
- Safety, Efficacy, & Pharmacokinetic Study of Tamibarotene to Treat Patients With Relapsed or Refractory APL
Conditions: Acute Promyelocytic Leukemia
2 Locations available
- T-Lymphocytes in Treating Patients With Relapsed or Refractory Low-Grade B-Cell Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia
Conditions: Leukemia - Lymphoma
3 Locations available
- Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
Conditions: Leukemia
82 Locations available
- Study of Dasatinib and All-Trans Retinoic Acid for Relapsed/Refractory and/or Elderly Patients With Acute Myelogenous Leukemia (AML)
Conditions: Acute Myelogenous Leukemia
1 Location available
- Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma
Conditions: Leukemia - Lymphoma
138 Locations available
- Epratuzumab, Cytarabine, and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
Conditions: Leukemia
46 Locations available
- Randomized Phase II Trial of Rituximab With Either Pentostatin or Bendamustine for Multiply Relapsed or Refractory Hairy Cell Leukemia
Conditions: Hairy Cell Leukemia
1 Location available
- Belinostat and Bortezomib in Treating Patients With Relapsed or Refractory Acute Leukemia or Myelodysplastic Syndrome
Conditions: Acute Lymphocytic Leukemia - Acute Myeloid Leukemia - Myelodysplastic Syndrome - Chronic Myelogenous Leukemia
1 Location available
- Entinostat and Clofarabine in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Poor-Risk Acute Lymphoblastic Leukemia or Bilineage/Biph
Conditions: Leukemia
3 Locations available
- Phase II Study of VELCADE for Relapsed or Refractory T-cell Prolymphocytic Leukemia
Conditions: Leukemia - Leukemia Acute Lymphoid Leukemia (ALL)
1 Location available
- Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Conditions: Leukemia - Acute Myeloid Leukemia - Acute Nonlymphocytic Leukemia
38 Locations available
- Study Examining the Combination of Lenalidomide and Azacitidine for Relapsed/Refractory CLL and SLL
Conditions: Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL)
1 Location available
- Azacitidine in Combination With Mitoxantrone, Etoposide Phosphate, and Cytarabine in Treating Patients With Relapsed and Refractory Acute Myeloid Leuk
Conditions: Leukemia
1 Location available
- Cyclosporine, Pravastatin Sodium, Etoposide, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Conditions: Adult Acute Megakaryoblastic Leukemia (M7) - Adult Acute Minimally Differentiated Myeloid Leukemia (M0) - Adult Acute Monoblastic Leukemia (M5a) - Adult Acute Monocytic Leukemia (M5b) - Adult Acute Myeloblastic Leukemia With Maturation (M2) - Adult Acute
1 Location available
- A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Conditions: Lymphoblastic Leukemia, Acute, Childhood - Myelogenous Leukemia, Acute, Childhood
2 Locations available
- Lenalidomide With or Without Rituximab in Treating Patients With Progressive or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Pro
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - Cutaneous B-cell Non-Hodgkin Lymphoma - Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue - Hepatosplenic T-
1 Location available
- Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral
Conditions: Leukemia - Lymphoma - Small Intestine Cancer
5 Locations available
- Sirolimus in Treating Young Patients With Relapsed or Refractory Acute Leukemia or Non-Hodgkin's Lymphoma
Conditions: Leukemia - Lymphoma
1 Location available
- Chemotherapy and a Donor Natural Killer Cell Infusion in Treating Patients With Relapsed or Persistent Leukemia or Myelodysplastic Syndrome After a Do
Conditions: Leukemia - Myelodysplastic Syndromes
1 Location available
- Lenalidomide and Alvocidib in Treating Patients With Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Conditions: Leukemia - Lymphoma
1 Location available
- Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Conditions: Relapsed or Refractory Chronic Lymphocytic Leukemia
14 Locations available
- Donor Stem Cell Transplant After Total-Body Irradiation in Treating Patients With Relapsed or Refractory Hematologic Cancer or Acute Myeloid Leukemia
Conditions: Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes
1 Location available
- PR104 in Treating Patients With Refractory/Relapsed Acute Leukemia
Conditions: Acute Myelogenous Leukemia - Acute Lymphocytic Leukemia
2 Locations available
- Pyrimethamine for the Treatment of Relapsed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Conditions: Chronic Lymphocytic Leukemia - Small Lymphocytic Leukemia
1 Location available
- Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Nelarabine in Patients With Relapsed/Refractory Lymphoid Malignancies
Conditions: Leukemia
1 Location available
- Carfilzomib in Patients With Relapsed Acute Myeloid or Acute Lymphoblastic Leukemia
Conditions: Leukemia
1 Location available
- POETIC Plerixafor as a Chemosensitizing Agent for Relapsed Acute Leukemia and MDS in Pediatric Patients
Conditions: Relapsed/Refractory AML - Relapsed/Refractory ALL - Secondary AML/MDS - Acute Leukemia of Ambiguous Lineage - AML - ALL
1 Location available
- Vincristine, Dexamethasone, Doxorubicin, and PEG-asparaginase (VPLD) and Metformin for Relapsed Childhood Acute Lymphoblastic Leukemia (ALL)
Conditions: Acute Lymphoblastic Leukemia
5 Locations available
- Phase 1/2 Safety and Efficacy of PLX3397 in Adults With Relapsed or Refractory Acute Myeloid Leukemia (AML)
Conditions: Acute Myeloid Leukemia
8 Locations available
- Temsirolimus, Dexamethasone, Mitoxantrone Hydrochloride, Vincristine Sulfate, and Pegaspargase in Treating Young Patients With Relapsed Acute Lymphobl
Conditions: Leukemia - Lymphoma
23 Locations available
- Trial of Cladribine, Cytarabine, Mitoxantrone, Filgrastim (CLAG-M) in Relapsed Acute Lymphoblastic Leukemia
Conditions: Acute Lymphoblastic Leukemia - Lymphoblastic Lymphoma - Burkitts Leukemia/Lymphoma - Chronic Myelogenous Leukemia
1 Location available
- An Open Label Study to Evaluate the Safety and Efficacy of Two Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Conditions: Leukemia, Myeloid, Acute
1 Location available
|